Dimenhydrinate and Clopidogrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dimenhydrinate (dimenhydrinate) and Clopidogrel (clopidogrel). Common drug interactions include headache among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Dimenhydrinate and Clopidogrel. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Dimenhydrinate?

Dimenhydrinate has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 6,644 Dimenhydrinate users. Check the latest studies of Dimenhydrinate.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.



On Jul, 14, 2026

75 people who take Dimenhydrinate and Clopidogrel together, and have interactions are studied.

Dimenhydrinate and Clopidogrel drug interactions.

What are the common drug interactions of Dimenhydrinate and Clopidogrel, by gender? *:

female:

  1. Headache (pain in head)
  2. Hemiparesis (weakness on one side of the body)
  3. Herpes zoster
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Infusion related reaction
  8. International normalised ratio increased
  9. Intestinal obstruction
  10. Localised oedema (fluid retention in a particular part of the body)

male:

  1. Pruritus (severe itching of the skin)
  2. Blood pressure increased
  3. Heart rate irregular
  4. Influenza like illness
  5. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  6. Respiratory tract congestion (blockage on respiratory system)
  7. Weight increased
  8. Blood pressure decreased
  9. Nephrolithiasis (calculi in the kidneys)
  10. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)

What are the common drug interactions of Dimenhydrinate and Clopidogrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diarrhoea

40-49:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Haemoglobin decreased

50-59:

  1. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  2. Stomatitis (inflammation of mucous membrane of mouth)
  3. Tinnitus (a ringing in the ears)
  4. Vision blurred
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Chest pain
  7. Abdominal adhesions (inflammation of abdomen)
  8. Acute myocardial infarction (acute heart attack)
  9. Blood creatine phosphokinase increased
  10. Blood pressure decreased

60+:

  1. Pruritus (severe itching of the skin)
  2. Blood pressure increased
  3. Influenza like illness
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Respiratory tract congestion (blockage on respiratory system)
  6. Weight increased
  7. Epistaxis (bleed from the nose)
  8. Haematemesis (vomiting of blood)
  9. Haemorrhage (bleeding)
  10. Nephrolithiasis (calculi in the kidneys)

What are the existing conditions these people have? *

  1. Depression: 10 people, 13.33%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 13.33%
  3. Nausea And Vomiting: 10 people, 13.33%
  4. Asthma: 9 people, 12.00%
  5. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 9 people, 12.00%
  6. Vision Blurred: 8 people, 10.67%
  7. Oesophageal Spasm (contraction of oesophagus): 8 people, 10.67%
  8. Abdominal Pain Upper: 8 people, 10.67%
  9. Urticaria (rash of round, red welts on the skin that itch intensely): 8 people, 10.67%
  10. Itching: 8 people, 10.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dimenhydrinate and Clopidogrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dimenhydrinate and Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dimenhydrinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dimenhydrinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopidogrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dimenhydrinate and clopidogrel (the active ingredients of Dimenhydrinate and Clopidogrel, respectively), and Dimenhydrinate and Clopidogrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: